高级检索
当前位置: 首页 > 详情页

Bile acid profiles in diabetic (db/db) mice and their wild type littermates

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Tongji Sch Pharm, 13 Hangkong Rd, Wuhan 430030, Peoples R China [2]Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China [3]Univ Adelaide, Discipline Med, Adelaide, SA, Australia [4]Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, SA, Australia [5]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pharm, Wuhan, Peoples R China [6]Humanwell Healthcare Grp Co Ltd, Med Res Ctr, Wuhan, Peoples R China [7]Jiangxi Univ Tradit Chinese Med, Nanchang, Peoples R China
出处:
ISSN:

关键词: Bile acid Diabetes db/db mice LC-MS/MS Real-time RT-PCR

摘要:
This study aimed to obtain information on bile acid profiles in diabetic (db/dh) mice and their wild type (wt) littermates for the understanding of pathogenesis and discovery of potential biomarkers of type 2 diabetes. Analytical methods based on protein precipitation or solid-phase extraction together with liquid chromatography-tandem mass spectrometry were developed for the determination of 25 bile adds in plasma, urine and feces samples collected from db/db and wt mice. GLP-1 concentration and hepatic genes related to bile acid synthesis were also investigated. The results showed that the concentrations of individual bile adds varied notably both interindividually and temporally. However, plasma, urine and feces samples displayed discriminating bile acid profiles between the db/db and wt groups, with the plasma profile showing the best differentiation capacity. In plasma and urine, the concentration variation of taurine-conjugated bile adds was more correlated with that of other taurine-conjugated bile acids, and vice versa for the unconjugated bile acids. Transcription of hepatic gene Cyp7b1 was downregulated, and Hsd3b7 upregulated in db/db mice. In conclusion, the bile add profile, particularly that in plasma, can distinguish the two animal groups and is a promising biomarker for type 2 diabetes. (C) 2016 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 3 区 分析化学 3 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 分析化学 3 区 药学
JCR分区:
出版当年[2014]版:
Q1 CHEMISTRY, ANALYTICAL Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 CHEMISTRY, ANALYTICAL Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Tongji Sch Pharm, 13 Hangkong Rd, Wuhan 430030, Peoples R China [2]Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:434 今日访问量:0 总访问量:419 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)